← back to search

Zhongqiu Liu

Guangzhou University of Chinese Medicine · CN
Area of research
Molecular Biology · Catalysis
Research interest
Research focused on In vivo and Matrine, with related work in Apoptosis, Dihydroartemisinin, Chromatography. Notable publications include 'Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling', 'Study of pharmacokinetic profiles and characteristics of active components and their metabolites in rat plasma following oral administration of the water extract of Astragali...', and 'Houttuynia cordata Thunb. and its bioactive compound 2-undecanone significantly suppress benzo(a)pyrene-induced lung tumorigenesis by activating the Nrf2-HO-1/NQO-1 signaling...'.
h-index
citations
720
works
34
NIH funding
primary concept
email

Recent publications

Classification of soluble proportions derived from coals and their correlation with coal type: Conjoint analyses of extraction, thermal dissolution and machine learning
Journal of the Energy Institute 2025cited by 11position: middledoi
Uncovering the active ingredients of Xinbao pill against chronic heart failure: A chemical profiling, pharmacokinetics and pharmacodynamics integrated study
Journal of Ethnopharmacology 2025cited by 7position: middledoi
HnRNPA2B1 promotes cardiac ferroptosis via m6A-dependent stabilization of PFN2 mRNA in myocardial ischemia-reperfusion injury
Free Radical Biology and Medicine 2025cited by 6position: middledoi
Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1N532/M550 and promoting its degradation
Journal of Pharmaceutical Analysis 2025cited by 3position: middledoi
CHPF2 as a novel biomarker and ponicidin as a potential therapeutic agent in hepatocellular carcinoma
Pharmacological Research 2025cited by 2position: middledoi
Evaluation of pharmacokinetics and metabolism of three marine-derived piericidins for guiding drug lead selection
Chinese Journal of Natural Medicines 2025cited by 2position: middledoi
Schisandrin B Targets PXR to Enhance Bile Acid Metabolism and Alleviate ANIT-Induced Cholestatic Liver Injury via Dual Pathways
International Journal of Biological Sciences 2025cited by 1position: middledoi
Oxidosqualene cyclases and cytochrome P450s involved in the biosynthesis of diverse triterpenes in Centipeda minima
International Journal of Biological Macromolecules 2025cited by 1position: middledoi
Ginsenosides exhibit potential therapeutic potential in photoaging by regulating keratinocyte ferroptosis
Journal of Ginseng Research 2025cited by 0position: middledoi
Formononetin inhibits colorectal cancer via the miR-490-3p/ABCC2 axis and synergizes with 5-fluorouracil: mechanistic insights and therapeutic implications
Biochemical Pharmacology 2025cited by 0position: middledoi
Ponicidin Promotes Hepatocellular Carcinoma Mitochondrial Apoptosis by Stabilizing Keap1‐PGAM5 Complex
Advanced Science 2024cited by 18position: lastdoi
FGF19‐Activated Hepatic Stellate Cells Release ANGPTL4 that Promotes Colorectal Cancer Liver Metastasis
Advanced Science 2024cited by 12position: middledoi
Calotropin attenuates ischemic heart failure after myocardial infarction by modulating SIRT1/FOXD3/SERCA2a pathway
Biomedicine & Pharmacotherapy 2024cited by 5position: middledoi
The water extract of Amydrium sinense (Engl.) H. Li ameliorates Isoproterenol-induced cardiac hypertrophy through inhibiting the NF-κB signaling pathway
Biomedicine & Pharmacotherapy 2024cited by 5position: middledoi
Reprogramming macrophage metabolism following myocardial infarction: A neglected piece of a therapeutic opportunity
International Immunopharmacology 2024cited by 4position: middledoi
Xinbao pill attenuated water retention by regulating the CaSR/AQP2 pathway in LAD-induced chronic heart failure rats
Journal of Traditional and Complementary Medicine 2024cited by 1position: middledoi
Xinbao Pill attenuated chronic heart failure by suppressing the ubiquitination of β-adrenergic receptors
Phytomedicine 2023cited by 22position: middledoi
Recent advances of oxidative stress in thromboangiitis obliterans: biomolecular mechanisms, biomarkers, sources and clinical applications
Thrombosis Research 2023cited by 18position: lastdoi
Formononetin, a bioactive isoflavonoid constituent from Astragalus membranaceus (Fisch.) Bunge, ameliorates type 1 diabetes mellitus via activation of Keap1/Nrf2 signaling pathway: An integrated study supported by network pharmacology and experimental validation
Journal of Ethnopharmacology 2023cited by 18position: middledoi
Structural Basis of the Interaction between Caffeic Acid and Keap1 in Activating Nrf2 Against Oxidative Stress
SSRN Electronic Journal 2023cited by 0position: middledoi
The Therapeutic Potential of Targeting Hsp90-Cdc37 Interactions inSeveral Diseases
Current Drug Targets 2022cited by 10position: lastdoi
Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus
Oxidative Medicine and Cellular Longevity 2021cited by 27position: middledoi
Discovery of higenamine as a potent, selective and cellular active natural LSD1 inhibitor for MLL-rearranged leukemia therapy
Bioorganic Chemistry 2021cited by 23position: middledoi
Therapeutic perspectives of heat shock proteins and their protein-protein interactions in myocardial infarction
Pharmacological Research 2020cited by 22position: middledoi
Role of Nrf2 and Its Activators in Cardiocerebral Vascular Disease
Oxidative Medicine and Cellular Longevity 2020cited by 22position: middledoi
Jian-Pi-Bu-Xue-Formula Alleviates Cyclophosphamide-Induced Myelosuppression via Up-Regulating NRF2/HO1/NQO1 Signaling
Frontiers in Pharmacology 2020cited by 22position: middledoi
Therapeutic potential of ALKB homologs for cardiovascular disease
Biomedicine & Pharmacotherapy 2020cited by 22position: middledoi
Houttuynia cordata Thunb. and its bioactive compound 2-undecanone significantly suppress benzo(a)pyrene-induced lung tumorigenesis by activating the Nrf2-HO-1/NQO-1 signaling pathway
Journal of Experimental & Clinical Cancer Research 2019cited by 86position: middledoi
The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells
Molecules 2017cited by 22position: lastdoi
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling
Oncotarget 2016cited by 121position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yuanyuan Cheng · Fudan University10 papers (2020–2025)Jinjun Wu · Guangzhou University of Chinese Medicine7 papers (2015–2025)Caiyan Wang · Fudan University7 papers (2020–2025)Linlin Lu · Sun Yat-sen University7 papers (2015–2020)Xiaoxiao Qi · Henan University of Technology4 papers (2017–2023)Liang Zheng · Guangzhou University of Chinese Medicine4 papers (2015–2020)Yanmei Lou · Guangzhou University of Chinese Medicine4 papers (2019–2024)Guiyu Zhang · Guangzhou University of Chinese Medicine4 papers (2015–2025)Ying Zhang · Guangzhou University of Chinese Medicine3 papers (2023–2025)Lin Jiang · Guangzhou University of Chinese Medicine3 papers (2023–2025)Zuhui Liang · Guangzhou University of Chinese Medicine3 papers (2023–2025)Yuanhang Xu · Guangzhou University of Chinese Medicine3 papers (2023–2025)Jian Shi · University of Kentucky3 papers (2013–2015)Huan Lan · Guangzhou University of Chinese Medicine3 papers (2023–2025)Muyan Kong · Guangzhou University of Chinese Medicine3 papers (2019–2025)Ruiyan Zheng · Guangzhou University of Chinese Medicine3 papers (2024–2025)Bixin Zhao · Guangzhou University of Chinese Medicine2 papers (2024–2025)Lan Tang · Guangzhou University of Chinese Medicine2 papers (2013–2025)Yuanping Wang · Fudan University2 papers (2023–2024)Wenqin Liu · Jiangxi University of Traditional Chinese Medicine2 papers (2015–2016)